EXTON, Pa., Feb. 25, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, an

STAINES-UPON-THAMES, United Kingdom, Feb. 25, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK) ("Mallinckrodt" or the "Company") today announced that the Company and its specialty generics-focused subsidiaries Mallinckrodt LLC, SpecGx LLC and certain other affiliates (collectively, "Specialty Generics") have reached an agreement in princ

NORTH CHICAGO, Ill., Feb. 25, 2020 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of February 21, 2020 its issued share capital, excluding treasury shares, is comprised of 1,481,908,359 shares of common stock with a par value of $0.0

VANCOUVER, Feb. 25, 2020 /PRNewswire/ - Choom™ (CSE: CHOO; OTCQB: CHOOF), one of the Canada's leading recreational cannabis retailers, is pleased to announce the opening of their next licensed cannabis retail store in Calgary, AB. The store, opening in the bedroom community of Shawcliffe, i

JERUSALEM, Feb. 25, 2020 /PRNewswire/ -- KAHR Medical Ltd., a biopharmaceutical company developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins known as Dual Signaling Proteins ("DSP") today announced that it has raised

STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) invites investors, analysts and the media to a R&D Day in Stockholm, Monday March 2, 2020, at 14:00 to 16:30 CET.The presentations will, among other things, address new clinical re

HELSINKI, Feb. 25, 2020 /PRNewswire/ -- Topline analysis confirms positive safety and tolerability of CDNF in advanced-stage Parkinson's disease patients, with encouraging biological responses as measured by PET imaging in some patients. Results from the second part of trial, in which all patients will receive CDNF for an additional six months, are expected in Q3 2020

LUND, Sweden, Feb. 25, 2020 /PRNewswire/ --  Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's management team will participate in the following upcoming investor conferences: Cowen and Company's 40th Annual Health Care Conference in

STOCKHOLM, Feb. 25, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the publication of scientific data on the mechanism of action of cobitolimod, the company's lead drug candidate in development for the treatment of moderate to severe ulcerative colitis. The paper, published in the peer-reviewed Journal of Crohns and Colitis (JCC),

HUNT VALLEY, Md., Feb. 25, 2020 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a pharmaceutical contract development and manufacturing organization (CDMO), announces the expansion of its aseptic filling capacity and capabilities with the addition of a new, fully robotic filling line.